Baird Financial Group Inc. Grows Position in DaVita Inc. $DVA

Key Points

• Baird Financial Group Inc. significantly increased its position in DaVita Inc. by 322.9% in Q1, acquiring a total of 26,959 shares valued at $4.12 million.
• DaVita reported earnings of $2.95 EPS for the last quarter, exceeding analyst expectations of $2.70, and had a revenue of $3.38 billion.
• Analysts' price targets for DaVita range from $148.00 to $169.00, with a consensus rating of "Hold" from multiple investment firms.

Baird Financial Group Inc. increased its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 322.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,959 shares of the company's stock after buying an additional 20,584 shares during the quarter. Baird Financial Group Inc.'s holdings in DaVita were worth $4,124,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of DVA. Iron Triangle Partners LP bought a new stake in DaVita during the fourth quarter worth $38,946,000. GAMMA Investing LLC grew its holdings in DaVita by 14,695.8% during the first quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock worth $35,919,000 after buying an additional 233,222 shares in the last quarter. Doma Perpetual Capital Management LLC grew its holdings in DaVita by 172.3% during the first quarter. Doma Perpetual Capital Management LLC now owns 288,360 shares of the company's stock worth $44,110,000 after buying an additional 182,476 shares in the last quarter. Northern Trust Corp grew its holdings in DaVita by 20.2% during the first quarter. Northern Trust Corp now owns 890,632 shares of the company's stock worth $136,240,000 after buying an additional 149,858 shares in the last quarter. Finally, Nuveen LLC bought a new stake in DaVita during the first quarter worth $20,218,000. Institutional investors own 90.12% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Truist Financial set a $148.00 price target on DaVita in a report on Friday, August 8th. Finally, Barclays dropped their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, DaVita currently has an average rating of "Hold" and an average price target of $164.00.

Insider Activity at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares in the company, valued at $3,905,700. This trade represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is currently owned by insiders.

DaVita Price Performance

Shares of DVA traded down $3.43 during midday trading on Monday, reaching $134.44. The stock had a trading volume of 882,176 shares, compared to its average volume of 672,085. The company's 50-day moving average is $139.24 and its 200 day moving average is $141.76. DaVita Inc. has a 12-month low of $126.07 and a 12-month high of $179.60. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. The company has a market capitalization of $9.61 billion, a price-to-earnings ratio of 13.22, a price-to-earnings-growth ratio of 0.99 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. During the same period in the prior year, the business posted $2.00 EPS. DaVita's quarterly revenue was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.